Navin Fluorine Q3 Review - Great Deal Of Growth Visibility: Dolat Capital  
A lab technician inspects a conical flask containing a mixture inside a research laboratory (Photographer: Stefan Wermuth/Bloomberg)

Navin Fluorine Q3 Review - Great Deal Of Growth Visibility: Dolat Capital  

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Navin Fluorine International Ltd. reported a healthy consolidated sales growth of 18.7% YoY to Rs 3.09 billion (marginal sequential de-growth of 3.1%).

Ebitda grew by 22.9% YoY to Rs 805 million and profit after tax growth stood at 29.7% YoY to Rs 589 million.

The company’s growth momentum in new-age businesses aided higher profitability, as order enquiries in contract research and manufacturing services and small de-bottlenecking capex’ bear fruits.

Headwinds in refrigerant gases are yet to relinquish, as realisations and volumes of R-22 gas continue to be under-pressure.

While Inorganic fluorides business has now seen a couple of client addition – which could improve growth visibility in ensuing quarters

Click on the attachment to read the full report:

Dolat Capital Navin Fluorine Q3FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.